The case for angioplasty in patients with symptomatic intracranial atherosclerosis

Frontiers in Neurology

Volumn 5 APR, Issue , 2014, Pages

  McTaggart, Ryan A ^a,b   Marks, Michael P ^c,d  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Intracranial atherosclerosis; Intracranial stenosis; Stenosis; Stents

Indexed keywords

BRAIN ATHEROSCLEROSIS; BRAIN DAMAGE; CAROTID ANGIOPLASTY; CEREBROVASCULAR ACCIDENT; HISTORY OF MEDICINE; HUMAN; MORBIDITY; MORTALITY; NEUROSURGERY; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SHORT SURVEY; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT RESPONSE;

EID: 84901007495     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00036     Document Type: Short Survey

References (37)

1. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 352:1305-16. doi:10.1056/NEJMoa043033.
2. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology (2006) 66:1187-91. doi:10.1212/01.wnl.0000208404.94585.b2.
3. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke (2008) 39:2396-9. doi:10.1161/STROKEAHA.107.505776.
4. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 365:993-1003. doi:10.1056/NEJMoa1105335.
5. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke (1996) 27:1974-80. doi:10.1161/01.STR.27.11.1974.
6. Weimar C, Goertler M, Harms L, Diener HC. Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch Neurol (2006) 63:1287-91. doi:10.1001/archneur.63.9.1287.
7. Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology (1990) 40:1541-5. doi:10.1212/WNL.40.10.1540.
8. Sacco RL, Roberts JK, Boden-Albala B, Gu Q, Lin IF, Kargman DE, et al. Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke (1997) 28:929-35. doi:10.1161/01.STR.28.5.929.
9. Heyden S, Heyman A, Goree JA. Nonembolic occlusion of the middle cerebral and carotid arteries-a comparison of predisposing factors. Stroke (1970) 1:363-9. doi:10.1161/01.STR.1.5.363.
10. Fields WS, Lemak NA. Joint study of extracranial arterial occlusion. X. Internal carotid artery occlusion. JAMA (1976) 235:2734-8. doi:10.1001/jama.235.24.2608.
11. Group T.E.I.B.S. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med (1985) 313:1191-200. doi:10.1056/NEJM198511073131904.
12. Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke (2003) 34:2361-6. doi:10.1161/01.STR.0000089017.90037.7A.
13. Asil T, Balci K, Uzunca I, Kerimoglu M, Utku U. Six-month follow-up study in patients with symptomatic intracranial arterial stenosis. J Clin Neurosci (2006) 13:913-6. doi:10.1016/j.jocn.2006.01.043.
14. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 113:555-63. doi:10.1161/CIRCULATIONAHA.105.578229.
15. Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology (2007) 69:2063-8. doi:10.1212/01.wnl.0000279338.18776.26.
16. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M, Warfarin-Aspirin Symptomatic Intracranial Disease Trial. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation (2007) 115:2969-75. doi:10.1161/CIRCULATIONAHA.106.622464.
17. Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, et al. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis (2011) 20:357-68. doi:10.1016/j.jstrokecerebrovasdis.2011.05.001.
18. Higashida RT, Tsai FY, Halbach VV, Dowd CF, Smith T, Fraser K, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg (1993) 78:192-8. doi:10.3171/jns.1993.78.2.0192.
19. Connors JJ III, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg (1999) 91:415-23. doi:10.3171/jns.1999.91.3.0415.
20. Clark WM, Barnwell SL, Nesbit G, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke (1995) 26:1200-4. doi:10.1161/01.STR.26.7.1200.
21. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke (1999) 30:1065-9. doi:10.1161/01.STR.30.5.1065.
22. Yoon W, Seo JJ, Cho KH, Kim MK, Kim BC, Park MS, et al. Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology (2005) 237:620-6. doi:10.1148/radiol.2372041620.
23. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke (2006) 37:1016-20. doi:10.1161/01.STR.0000206142.03677.c2.
24. Wojak JC, Dunlap DC, Hargrave KR, Dealvare LA, Culbertson HS, Connors JJ III. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol (2006) 27:1882-92.
25. Nguyen TN, Zaidat OO, Gupta R, Nogueira RG, Tariq N, Kalia JS, et al. Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multicenter study. Stroke (2011) 42:107-11. doi:10.1161/STROKEAHA.110.583245.
26. Dumont TM, Kan P, Snyder KV, Hopkins LN, Siddiqui AH, Levy EI. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Neurosurgery (2012) 71:1103-10. doi:10.1227/NEU.0b013e318271bcb8.
27. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol (1998) 19:1525-33.
28. Suh DC, Kim JK, Choi JW, Choi BS, Pyun HW, Choi YJ, et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol (2008) 29:781-5. doi:10.3174/ajnr. A0922.
29. Qureshi AI, Tariq N, Hassan AE, Vazquez G, Hussein HM, Suri MF, et al. Predictors and timing of neurological complications following intracranial angioplasty and/or stent placement. Neurosurgery (2011) 68:53-60; discussion 60-61. doi:10.1227/NEU.0b013e3181fc5f0a.
30. Miao ZR, Feng L, Li S, Zhu F, Ji X, Jiao L, et al. Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center. Neurosurgery (2009) 64:79-84; discussion 84-75. doi:10.1227/01.NEU.0000335648.31874.37.
31. Kurre W, Berkefeld J, Brassel F, Bruning R, Eckert B, Kamek S, et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry. Stroke (2010) 41:494-8. doi:10.1161/STROKEAHA.109.568063.
32. Zhu SG, Zhang RL, Liu WH, Yin Q, Zhou ZM, Zhu WS, et al. Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis. Eur J Vasc Endovasc Surg (2010) 40:499-506. doi:10.1016/j.ejvs.2010.05.007.
33. Al-Ali F, Cree T, Hall S, Louis S, Major K, Smoker S, et al. Predictors of unfavorable outcome in intracranial angioplasty and stenting in a single-center comparison: results from the Borgess Medical Center-Intracranial Revascularization Registry. AJNR Am J Neuroradiol (2011) 32:1221-6. doi:10.3174/ajnr. A2530.
34. Jiang WJ, Cheng-Ching E, Abou-Chebl A, Zaidat OO, Jovin TG, Kalia J, et al. Multicenter analysis of stenting in symptomatic intracranial atherosclerosis. Neurosurgery (2012) 70:25-30; discussion 31. doi:10.1227/NEU.0b013e31822d274d.
35. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Braunlich S, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol (2011) 58:1105-9. doi:10.1016/j.jacc.2011.05.034.
36. Vajda Z, Guthe T, Perez MA, Heuschmid A, Schmid E, Bazner H, et al. Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons. AJNR Am J Neuroradiol (2011) 32:1942-7. doi:10.3174/ajnr. A2644.
37. Vajda Z, Guthe T, Perez MA, Kurre W, Schmid E, Bazner H, et al. Prevention of intracranial in-stent restenoses: predilatation with a drug eluting balloon, followed by the deployment of a self-expanding stent. Cardiovasc Intervent Radiol (2013) 36:346-52. doi:10.1007/s00270-012-0450-9.